PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-Jun-2025 Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Riliprubart
30-Jun-2025 ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP ProQR
30-Jun-2025 Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs Stalicla
30-Jun-2025 STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer STORM Therapeutics
30-Jun-2025 Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations Tilray Medical
30-Jun-2025 UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder UCB
30-Jun-2025 Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026 Viromed Medical AG
30-Jun-2025 ANGLE PLC Announces Result of 2025 Annual General Meeting ACCESS Newswire
30-Jun-2025 New Report Analyzes Gaps in State Health Insurance and AI Consumer Protections ACCESS Newswire
30-Jun-2025 BULLETIN from EXTRAORDINARY GENERAL MEETING in Senzime AB (publ) ACCESS Newswire
30-Jun-2025 Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH) Marinomed Biotech AG
30-Jun-2025 Hospitals at Cybersecurity Crossroads: Projected Medicaid Cuts Threaten 25% of U.S. Hospitals - Black Book Research ACCESS Newswire
30-Jun-2025 The Increasing Value Of The Diagnostic Imaging Market By 2035 VMR
30-Jun-2025 Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs ACCESS Newswire
30-Jun-2025 Laverock Therapeutics expands seed funding and announces key milestone progress Laverock Therapeutics
30-Jun-2025 Change in Number of Shares and Votes in Alligator Bioscience AB ACCESS Newswire
30-Jun-2025 IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation ACCESS Newswire
30-Jun-2025 US MedTech Disruptor OIC International Expands Into Asia, Central, and South America With Affordable Trauma Innovation ACCESS Newswire
30-Jun-2025 Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient ACCESS Newswire
30-Jun-2025 Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx ACCESS Newswire